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ABSTRACT
Homing endonucleases (HEs) cleave long ( 20bp)
DNA target sites with high site specificity to cata-
lyze the lateral transfer of parasitic DNA elements. In
order to determine whether comprehensive compu-
tational design could be used as a general strategy
to engineer new HE target site specificities, we used
RosettaDesign (RD) to generate 3200 different
variants of the mCreI LAGLIDADG HE towards 16
different base pair positions in the 22bp mCreI
target site. Experimental verification of a range of
these designs demonstrated that over 2/3 (24 of
35 designs, 69%) had the intended new site specifi-
city, and that 14 of the 15 attempted specificity shifts
(93%) were achieved. These results demonstrate the
feasibility of using structure-based computational
design to engineer HE variants with novel target
site specificities to facilitate genome engineering.
INTRODUCTION
Homing endonucleases (HEs) are native proteins found
in all domains of life that use their highly site-speciﬁc
endonucleolytic activity to initiate and target the lateral
transfer of parasitic DNA elements. These parasitic DNAs
are often self-splicing inteins or introns that encode their
cognate HEs (1–3). HE proteins can be subdivided into
ﬁve families based on shared protein sequence motifs. The
LAGLIDADG homing endonucleases (LHEs) comprise
the largest of these families with over 400 predicted
members (4), and typically have DNA target sites of
22bp together with a shared 3D-fold (Figure 1A) (3).
The combination of long target sites and high site spe-
ciﬁcity of cleavage make HEs potentially useful for
genome engineering and therapeutic applications (5,6).
However, realizing this potential requires the ability to
generate HE variants that target speciﬁc genes or
genomic targets in living cells. We and others have
reported the use of experimental approaches to success-
fully redirect LAGLIDADG and His-Cys box HEs to new
target site speciﬁcities (7–17). These efforts have relied
chieﬂy on structure-driven experimental protocols in
which large libraries of variant HE proteins are screened
to identify members with the desired new cleavage speci-
ﬁcity. Recent examples of this approach were the gener-
ation of I-CreI variant HEs with high speciﬁcity for target
sites in genes responsible, when mutant, for human
X-linked severe combined immune deﬁciency (X-SCID)
or xeroderma pigmentosum group C (XPC) (14,15).
We recently reported an alternative, structure-based
computational approach to alter HE target site speciﬁcity.
This approach was used to design variants of the I-MsoI
LHE that can cleave target sites containing 1, 3 or 4
interrelated base pair changes (18,19). Computational
design provides an attractive alternative to the experimen-
tal approaches described above: New target site
speciﬁcities can be generated rapidly, and without the
need to create or screen large libraries of protein
variants for each new target site/HE combination. Here
we demonstrate the ability of computational design to
generate variants of the LHE mCreI with altered
speciﬁcities at all target site base pair positions that
make direct or water-mediated contacts in the mCreI
22bp target site. The high success rate of this approach
indicates that computational design can provide a rapid
and effective way to generate target site-speciﬁc variants
of many HE proteins for genome engineering or clinical
applications.
MATERIALS AND METHODS
Computational methods
mCreI designs were generated using RosettaDesign (RD),
a macromolecular modeling and design suite (20). RD
seeks to minimize the energy of a macromolecular system
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order to design novel mCreI target site speciﬁcities using
RD, we simulated the desired change in target site DNA
and then allowed RD to remodel and/or mutate nearby
amino acids to accommodate the new DNA target (21–
23). Only amino acids close enough to contact the
simulated base pair change were allowed to mutate; other
amino acids in the vicinity were allowed to alter their orien-
tation if needed to accommodate local changes in the DNA
interface, whereas more distant amino acids were held
ﬁxed. Amino acid side chain conformations and identities
were sampled by randomly selecting a position, then
substituting a randomly selected side chain rotamer con-
formation from the Dunbrack backbone-dependent
rotamer library (24). RD also allowed water molecules to
be inserted at canonical positions previously identiﬁed in
high resolution structures of DNA–protein interfaces (22).
Amino acid conformations and associated hydration
patterns that improved the energy of the mCreI-target
site DNA complex were preferentially accepted during
design runs. With iteration, this process converged on
amino acid substitution(s) that generate energetically fa-
vorable and speciﬁc designs for each target site position
and base pair possibility. These designs were then
rank-ordered based on their predicted speciﬁcity for the
altered DNA target site and their structural plausibility,
as described below.
This design approach was applied to generate mCreI
models towards all single base pair variant possibilities in
the DNA target site (Figure 1B and C). The central 4bp
positions in the mCreI target site (positions  2 to+2) were
excluded, because mCreI makes no sequence-speciﬁc
contacts to these positions that could serve as a basis for
target speciﬁcity (Figure 1B and C). Designs for base pair
positions ±11 were also attempted, but did not converge
on useful design solutions. These sites are more distant
from the protein backbone and hence there are fewer
opportunities for introducing new side chain–base inter-
actions beyond the single water-mediated contact, from
S32 to guanine, at this base pair position (Figure 1C).
Fifty independent iterations of the above protocol were
performed against the remaining 16bp target positions in
order to ensure adequate sampling of design space to yield
3200 designs (16 target site positions 4bp possibilities/
position 50 iterations).
Overall design favorability was assessed by a combin-
ation of a RD-generated speciﬁcity score and by visual
inspection of molecular models of designs to assess
Figure 1. mCreI and DNA target site structure. (A) mCreI is a monomerized version of the native I-CreI homodimeric LAGLIDADG homing
endonuclease protein shown here (30). (B) Sequence of the native I-CreI/mCreI target site with positions of phosphodiester backbone cleavages in the
top (downward ﬁlled triangle) and bottom (upward ﬁlled triangle) strands indicated on the sequence of the top strand of native target site DNA.
Target site cleavage across the minor groove leaves 4-base, 30-OH extended cohesive ends. Note the partially palindromic nature of the native target
site sequence. (C) mCreI makes both direct and water-mediated contacts with target site DNA predominantly via amino acid residues located
predominantly in b-sheets that lie in the major groove of target site DNA. The contact map is an updated and redrawn version of the original
contact map shown in (34).
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estimated by computationally repacking each design with
its cognate (design) target site and competitor target sites
that contained the remaining 3bp possibilities at each
design position. The predicted binding energies of
designs bound to cognate or to competitor target sites
were then used to estimate the binding preference of
designs for each target site (25). Visual inspection of the
DNA interface of designs allowed us to identify energet-
ically favorable designs that had the best (i.e. most struc-
turally plausible and well-oriented) hydrogen bond and/or
non-polar interactions with target DNA base pairs, and to
discard designs that despite high predicted speciﬁcities
made no contacts to the design base pair. We discarded
 25% of designs with >80% predicted speciﬁcity on the
basis of unfavorable structural properties. The added
value of visual inspection for structural plausibility with
the incorporation of human intuition has recently been
highlighted by the success of the multiplayer online
game for protein structural prediction ‘FoldIt,’ based on
RD (http://fold.it/portal/) (26).
Recombinant protein puriﬁcation
The symmetry of the mCreI DNA–protein interface
allowed us to analyze one design for each base pair and
position as representative of both ‘minus’ and ‘plus’ half
site design solutions (Figure 1). Thus we used site-directed
mutagenesis to generate the open reading frames for all
‘minus’ half site design variants. In brief, oligonucleotides
encoding design amino acid substitutions were used to
amplify the mCreI gene in PCR reactions that contained
200mM dNTPs (New England Biolabs), 0.4nM of each
primer,  30–100ng of the template mCreI gene in pET-
15bHE, and 1 unit of Phusion thermophilic DNA poly-
merase in 1 High Fidelity Phusion buffer (Finnzymes).
Ampliﬁed fragments were puriﬁed by agarose gel electro-
phoresis and silica DNA binding (Qiagen), then digested
with NcoI and NotI prior to ligation into the T7 expres-
sion vector pET-15bHE. Plasmids were then transformed
into expression-competent C2566 Escherichia coli cells
(New England Biolabs), followed by growth on plates
containing 100mg/ml carbenicillin and 0.2% (w/v)
glucose. Protein expression was performed by inoculating
individual colonies into 100ml auto-induction medium
[10g/l tryptone, 5g/l yeast extract, 0.5% glycerol, 0.05%
glucose, 0.2% a-lactose, 0.5M (NH4)2SO4,1MK H 2PO4,
1MNa 2HPO4, 1mM MgS04,5 0mM FeCl3,2 0mM CaCl2,
10mM MnCl2,1 0mM ZnSO4,2mM CoCl2, 2.0mM CuCl2,
2.0mM NiCl2, 2.0mMN a 2MoO4, 2.0mMN a 2SeO3,
2.0mMH 3BO3], followed by growth for 8–12h at 37 C
and then a shift to 18 C for an additional 24h when pro-
gressive glucose depletion from the growth medium lead
to mCreI expression (27).
Recombinant mCreI proteins were puriﬁed using 1ml
HisTrap Ni protein puriﬁcation columns and an
AKTAExpress protein puriﬁcation machine (GE
Healthcare). In brief, bacterial pellets were resuspended
in binding buffer (300mM NaCl, 50mM NaPO3 pH 8.0,
20mM imidazole, 2mM PMSF, 2.5mM benzamidine),
lysed and ﬁltered, then applied to columns and washed
with 20ml wash buffer (300mM NaCl, 50mM NaPO3
pH 8.0, 20mM imidazole). Protein was eluted using a
three-step, 19ml non-linear gradient of wash and elution
buffers. Elution buffer consisted of 300mM NaCl, 50mM
NaPO3 pH 8.0, 500mM imidazole. The elution steps con-
sisted of a 2ml linear gradient of 0–30% elution buffer, a
15ml linear gradient of 30–60% elution buffer and a ﬁnal
2ml linear gradient of 60–100% elution buffer. Fractions
(1ml) were monitored by UV absorption, and those con-
taining mCreI were identiﬁed by gel electrophoresis of
10ml aliquots of each fraction. Native mCreI and mCreI
designs eluted at  312mM imidazole (corresponding
to 40% elution/60% wash buffer). mCreI-containing
fractions were pooled, concentrated using a 10kD
protein concentrator (Millipore) to  100ml, and then
buffer exchanged by diluting with 7ml of protein buffer
(300mM NaCl, 50mM NaPO3 pH 8.0, 5% glycerol)
followed by reconcentration to  100ml. Protein
concentrations were quantiﬁed by Bradford assay
(Bio-Rad), then stored in 150mM NaCl, 25mM NaPO3
pH 8.0, 52% glycerol at  20 C.
In vitro cleavage assays
A competitive in vitro ‘bar code’ cleavage assay was de-
veloped to determine mCreI speciﬁcity at each target site
position for all four base pair possibilities (Figure 2). The
target site library consisted of 61 plasmids, each con-
taining a different mCreI target site with one of four
base pair possibilities at each target site position from
 10 to +10 (Figure 1B) cloned into pDR–GFP-univ, a
modiﬁed version of the pDR–GFP recombination
reporter plasmid (28); (see http://depts.washington.edu/
monnatws/plasmids/pDR-GFP%20univ.pdf for details).
This provided a common target site library that could be
used for both in vitro and in vivo cleavage assays. Sequence-
veriﬁed target site plasmids were used as substrates to
amplify different target sites for in vitro cleavage analyses.
In brief, PCR primers were chosen to place each tar-
get site position at the center of an amplicon that
could be readily distinguished on the basis of amplicon
size from fragments containing the other three base
pair possibilities at each target site base pair position
(Figure 2). PCR reactions contained 200mM dNTPs
(New England Biolabs), 0.4nM of each primer, 50ng
of the highly puriﬁed pDR–GFP-Cre template, 1.5M
betaine and 1U of Taq thermophilic DNA polymerase
in 1  Thermopol buffer (New England Biolabs). Betaine
was required for successful ampliﬁcation, and necess-
itated that ampliﬁcations be performed immediately
after addition. PCR fragments were puriﬁed (Qiagen
PCR Cleanup) and quantitated by UV spectrometry
(Nanodrop), then combined to form substrate pools in
which all four base pair possibilities at each target site
base pair position were present in equimolar amount.
Cleavage assays were performed in a ﬁnal volume of
10ml that contained the four pooled substrates for each
target site base pair position (total cleavage substrate con-
centration was 65nM) in 10mM MgCl2, 20mM TrisCl
pH 8.0 and from 20 to 66nM mCreI protein. Digestions
were performed for 60min at 37 C, then stopped by
4332 Nucleic Acids Research, 2011,Vol.39, No. 10adding 100mM EDTA, 0.1% SDS and 1.3% Ficoll 400
prior to electrophoresis through a 1% agarose/TAE gel to
separate substrate and cleavage products. Gels were
stained in 1mg/ml ethidium bromide for 40min followed
by destaining in water for 10min prior to digital imaging
under 302nm UV light. The intensities of substrate and
cleavage product bands were quantiﬁed using TotalLab
Quant image analysis software (www.totallab.com/
products/totallabquant/) (Supplementary Table S1).
RESULTS
Cleavage speciﬁcity proﬁling of mCreI
We used the in vitro bar code assay described above to
systematically determine the DNA cleavage speciﬁcity of
mCreI. This provided systematic and quantitative data to
guide and assess our design efforts. mCreI is a mono-
merized version of the well-characterized homodimeric
I-CreI LHE that we generated in order to facilitate both
protein and genome engineering applications (29,30). The
target site library for these assays consisted of all single
base pair variant mCreI DNA target sites cloned into a
common target site plasmid (pDR–GFP-univ; Figure 2A).
The same target site library was also used to determine
cleavage speciﬁcity in human cells, where mCreI expres-
sion and target site cleavage leads to homologous recom-
bination with the generation of GFP-positive cells that
can be detected and quantiﬁed by ﬂow cytometry (30)
(H. Li and U. Ulge, unpublished data).
Target site speciﬁcity for mCreI ranged from highly
speciﬁc at some base pair positions (e.g. ±3, 4, 9 and
10, where only a single base pair variant was cleavage
sensitive), to near-complete degeneracy at other positions
(e.g.  2,  5 and ±8, where all four base pair variant
target sites displayed detectable cleavage) (Figure 2B;
Supplementary Figure S1 top row and additional results
not shown). These results systematically extended existing
data on mCreI target site speciﬁcity by providing quanti-
tative data over a range of protein concentrations, and
thus substantially extended our prior analysis of highly
complex libraries of potential target sites that were per-
formed at a single protein concentration, and in which
only the most cleavage-sensitive sites are likely to have
been reliably identiﬁed (31).
Generation and experimental veriﬁcation of mCreI designs
RD was used as a comprehensive computational frame-
work for biomolecular modeling and design to determine
the degree to which mCreI could be computationally en-
gineered to cleave single base pair variant DNA target
sites. We used RD to generate 3200 mCreI designs from
which we selected a subset of 117 for further analysis.
These represented the most energetically stable designs,
and were the designs predicted to be most speciﬁc, of
the 50 designs generated for each design target. In in-
stances where these two designs were identical we
excluded one from further analysis, thus reducing 128
initial high ranking designs to 117.
Figure 2. In vitro cleavage assay. (A) In vitro ‘bar code’ cleavage assay developed to determine simultaneously cleavage speciﬁcity and activity for all
four base pair possibilities at single target site positions in a single tube/single gel lane assay. Four primer pairs were used to amplify cleavage
substrates from target site plasmids with the target site at the center of the resulting PCR fragment (left panel). Fragment lengths specify the base
pair at the target site query position (ranging from 2200 base pairs for ‘A’ sites to 1320 base pairs for ‘T’ sites; right panel). (B) Pools of four
substrates were cleaved in a single tube digest prior to separating substrates and cleavage products in a single lane of an agarose gel. Cleavage of
substrate molecules at the centrally located mCreI target site generates two equal length cleavage products and a ‘bar code’ linking substrate and
cleavage band intensities that reports cleavage activity and speciﬁcity simultaneously for all four base pair possibilities at single target site base pair
positions. Examples of base-speciﬁc (central panel) and non-speciﬁc or degenerate cleavage patterns (right panel) are depicted.
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combination of RD-predicted speciﬁcity, favorable
energies and structural plausibility at all design base pair
positions and across a range of predicted speciﬁcities
(Figure 3). We experimentally characterized the cleavage
speciﬁcity and activity of 35 mCreI design variants repre-
senting 13 different single base pair-variant target sites, as
well as four different designs against the native mCreI
target site (Table 1). Some of the included designs had
small amino acid variations at the same residue because
in silico calculations did not provide a single best solution
despite iterative design attempts (see, e.g. Designs 5–8
against target  9C).
The in vitro speciﬁcity and activity of individual mCreI
designs were assayed using the competitive ‘bar code’
cleavage assay shown in Figure 2 (Supplementary
Figure S1). We used a simple and intuitive metric for spe-
ciﬁcity that assessed the number of single base pair variant
target sites at a given base pair position that could be
cleaved by a protein design at low protein concentrations
(20 or 33nM). ‘Highly speciﬁc’ mCreI design variants
cleaved only one target site base pair at the design position,
whereas ‘degenerate’ or ‘non-speciﬁc’ design variants
detectably cleaved all four single base pair variants at
the design position. In Table 1, we list the speciﬁcity of
each design in comparison to WT, with ‘+ +’ designating
designs that cleave as many target variants at the design
position as the WT enzyme does.
Among the13 novelsingle base pair speciﬁcity shifts that
were attempted, only one (for  5A) was not achieved for
an overall success rate of 93%. Eight novel speciﬁcities
(for  10G,  9C,  9G,  7G,  6T,  5C,  4C and+5G)
were achieved while maintaining cleavage activity com-
parable to native mCreI (Designs 3, 7, 10, 19, 23, 28, 31
and 35, respectively; Supplementary Figure S1). Four
additional designs had the intended novel speciﬁcity,
but displayed reduced cleavage activity. Two designs
against the native mCreI target site showed increased
speciﬁcity at native target site positions  10 and  6
that is most readily apparent at high enzyme concentra-
tions (Designs 2 and 20; Supplementary Figure S1).
Two-thirds of our designs (24 of 35, 69%) thus exhibited
the intended speciﬁcity shift in conjunction with catalytic
activity. Design 12, for  8G, represented an interesting
15th novel speciﬁcity: from  8A to C, as opposed to the
original design target  8G. This was the sole design that
was speciﬁc and catalytically active though did not
exhibit the intended speciﬁcity shift.
The mCreI design successes summarized above repre-
sent three classes of outcome with different combinations
of speciﬁcity and activity that each may be useful for
speciﬁc engineering applications. Class I, containing four
designs, had the highest average RD-predicted speciﬁcity
of 87% (Figure 7; data not shown). These designs were
more speciﬁc than mCreI, especially at high-protein con-
centrations, but were generally less active than native
mCreI (Table 1, Supplementary Figure S1). Of note, our
prior analyses of mCreI and mMsoI (30) emphasized that
even modest levels of catalytic activity are sufﬁcient to
promote in vivo cleavage-dependent recombination in
human cells. Molecular modeling of Class I designs
indicated two different strategies that conferred high spe-
ciﬁcity: suppressing cleavage of a native base pair while
favoring cleavage of an alternative base pair and designing
toward the native base pair while suppressing cleavage of
other tolerated base pairs. Design 11 is an example of the
ﬁrst of these strategies (Figure 4).
Class II designs included seven mCreI variants that
cleaved design base pairs with speciﬁcities comparable to
mCreI. The average RD-predicted speciﬁcity of Class II
enzymes was 77%, and all seven Class II designs were
approximately as active as native mCreI (Table 1;
Supplementary Figure S1). Design 28, a representative
example of Class II designs (Figure 5), preferentially
cleaved  5C and to a lesser extent  5T. Native mCreI,
in contrast, preferentially cleaved  5G and to a lesser
extent  5A (Supplementary Figure S1 top row).
Class III designs included four mCreI variants with
broader cleavage speciﬁcities relative to native mCreI,
and an average RD-predicted speciﬁcity of 65%. All
four Class III designs cleaved both their design base pair
and the native base pair at the design position. Design 22,
for  6G, is representative of Class III designs (Figure 6).
Designs with lower overall speciﬁcity may be practically
useful when a desired novel speciﬁcity can be achieved
despite retaining the ability to cleave the native target
site base pair.
DISCUSSION
We used the Rosetta protein design methodology to
generate variants of the monomeric LAGLIDADG
Figure 3. Graphical representation of mCreI computational design
output. A library of 3200 mCreI designs was generated using RD
against all 4 base pair possibilities at each target site position from
±3 to ±11 (see text). The RD-predicted speciﬁcities and energies of
117 designs are plotted that represent the most energetically stable or
the most speciﬁc of the 50 designs generated for each design target.
Only a single design is plotted for instances in which the most stable
and most speciﬁc design were the same. Experimentally validated
design speciﬁcities are represented by squares labeled with the design
base pair and position. Useful designs for target site positions ±11 did
not emerge and are not represented, nor is a design that cleaved  8C
that was an unanticipated—albeit a sequence-speciﬁc—outcome of an
attempt to design for  8G (Table 1, Design 12).
4334 Nucleic Acids Research, 2011,Vol.39, No. 10homing endonuclease (LHE) mCreI that were speciﬁc for
target sites containing a broad range of single base pair
substitutions. Twenty-four of 35 mCreI design variants
(69%) that were experimentally characterized had the
intended new site speciﬁcities and 14 of 15 (93%) of at-
tempted speciﬁcity shifts were achieved. This work repre-
sents the ﬁrst systematic application of structure-based
computational design to generate large numbers of cata-
lytically active homing endonuclease proteins, with novel
speciﬁcities at many different positions, in an LHE DNA–
protein interface.
The 15 engineered speciﬁcities described above were
identiﬁed among 3200 computational designs that were
rank ordered on the basis of RD-predicted speciﬁcity
and structural plausibility. This approach was largely suc-
cessful in predicting the speciﬁcity of individual mCreI
designs (Figure 7). The average predicted speciﬁcity of
Class I designs was 10% higher than that of Class II
Table 1. Summary of experimentally validated mCreI computational designs
Design number Design
speciﬁcity
a
Residue substitutions
(native/residue/design)
Cleavage
activity
b
Speciﬁcity
shift
b
Design
Class
b
1 A-10A N30K   
2 A-10A N30K Y33H + + + + I
3 A-10G N30R Y33H + ++ + II
4 A-10G N30R S32R Y33H + + ++
5 A-9C N30R Q38A + ++ +
6 A-9C N30R Q38S + ++
7 A-9C N30R Q38D + ++ + II
8 A-9C N30R Q38N + +  
9 A-9G Q38K +  
10 A-9G N30D Q38K + ++ III
11 A-8G K28D S40R + + + + I
12 A-8G
c Q26R K28D S40R + + + + I
13 A-8G K28N S40R + + + +
14 A-8G K28T S40R + +  
15 A-8G K28D S40K +  
16 A-7G K28V I77R + +  
17 A-7G K28E I77R + +  
18 A-7G K28V T42R I77R + ++ +
19 A-7G K28V T42K I77R + ++ + II
20 C-6C Q26R + ++ + + I
21 C-6C Q26S S40R + + + +
22 C-6G Q26T I77R + + III
23 C-6T I77R + ++ + II
24 C-6T I77K + +  
25 G-5A I24V T42R R68T + +  
26 G-5A I24V T42K R68T + +  
27 G-5C I24T Q44R R68T + + + +
28 G-5C I24K R68T + + ++ + II
29 T-4A Q44T R70N D75Q + + III
30 T-4C Q44L R70N D75K + ++
31 T-4C Q44L R70D D75K + ++ + II
32 T-4C Q44R R70N D75S +  
33 T-4C Q44R R70D D75S + ++
34 T-4G Q44L R70Q D75E + + III
35 C+5G I220K R264T + ++ + II
Cleavage activity and speciﬁcity are shown as ‘ ’ for no activity/speciﬁcity; ‘+’ for reduced activity/speciﬁcity; ‘+ +’ for levels comparable to native
mCreI; and ‘+ + +’ for greater than native levels. Activity and speciﬁcity assessments were made at 20nM protein concentrations with the exception of
designs against native base pairs (e.g. Designs 1, 2, 20 and 21) where speciﬁcity and activity were assessed using data across all protein concentrations
tested (20–66nM). The most successful designs for each novel speciﬁcity are shown in bold, with Class designations given to the right (see text).
Cleavage and speciﬁcity data used to prepare Table 1 are summarized in Supplementary Figure S1. The ‘Design speciﬁcity’ column lists the native
base pair speciﬁcity of mCreI followed by the target base pair position number and the design speciﬁcity to the right. Color shading of design
substitutions indicates residue substitutions previously identiﬁed by Seligman and colleagues (yellow-boxed substitutions) (7,12), or by Pa ˆ ques and
colleagues (magenta-boxed substitutions) (9,10,15). Both of these groups used structure-guided random mutagenesis at selected positions in the native
I-CreI DNA interface. The blue-boxed substitutions of Gao and colleagues (17) were generated after visual inspection of the I-CreI structure. Of
note, our Design 4 32R and 33H substitutions were not combined by Seligman and colleagues and 30D and 28D in Designs 10 and 15 both appeared
as glutamates in previous work in contrast to our computationally predicted aspartates. Color shading of design substitutions indicates residue
substitutions previously identiﬁed by Seligman and colleagues (yellow-boxed substitutions) (7,12), or by Pa ˆ ques and colleagues (magenta-boxed
substitutions) (9,10,15). Both of these groups used structure-guided random mutagenesis at selected positions in the native I-CreI DNA interface. The
blue-boxed substitutions of Gao and colleagues (17) were generated after visual inspection of the I-CreI co-crystal structure.
aDesign speciﬁcity is indicated by the native base at the numbered design position followed by the design base at that position.
bCleavage activity of native mCreI is deﬁned as ‘+ +’, whereas cleavage speciﬁcity equivalent to native mCreI at a given position is deﬁned as ‘+ +’.
Class designations encompass both cleavage activity and speciﬁcity, with Class I designs being more speciﬁc, Class II as speciﬁc albeit altered, and
Class III designs as less speciﬁc/more relaxed than native mCreI.
cDesign 12 was originally directed at  8C but was found to have a different speciﬁcity, for  8G, when characterized.
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the mCreI DNA–protein interface is highly symmetric, all
of our ‘minus’ half site designs should be readily
transferrable to comparable positions in the ‘+’ or right
mCreI half site (Figure 1). We demonstrated this predic-
tion explicitly with Design 35, in which the design to+5G
was shown to have the same speciﬁcity/activity proﬁle as
its mirror image Design 28 to  5C.
We hypothesized at the outset that there might be a
correlation between overall free energy, energetic stability
and catalytic activity of designs on their design target sites.
However, we found no correlation that would allow us
to computationally predict design activity (Figure 3,
Supplementary Figure S1). There are at least two explan-
ations for this low concordance. First, different regions of
the DNA–protein interface may have different tolerances
for residue substitutions. When this source of variability
was removed by comparing multiple designs for the same
target site and base pair, RD was much better at predict-
ing activity as well as speciﬁcity for a design target.
Examples include Designs 2 through 4 for target site
position  10A, where successive mCreI designs were
progressively more active (Table 1 and Supplementary
Figure S1); and Designs 16 and 19 for  7G which were
more active than Designs 17 or 18. In both instances, RD
successfully predicted the relative activity levels of the en-
zymes based on their calculated energies (Supplementary
Figure S1; additional data not shown).
A second potential reason for the inconsistent relation-
ship between predicted energy and activity is related to the
design process: designs were selected on the basis of favor-
able energy, predicted speciﬁcity and structural plausibil-
ity. This approach makes engineering direct and
transparent, but favoring designs with direct contacts to
design base pairs may sacriﬁce favorable interactions with
neighboring residues that inﬂuence catalysis. It should be
possible to address this issue by developing multi-state
design protocols to track both speciﬁcity and energy sim-
ultaneously, in order to explicitly optimize trade-offs
during the design process.
Many of our most successful designs involved G:C as
opposed to A:T base pairs. RD is particularly good at
designing new guanine contacts because major groove
electronegative atoms—the N7 and the carbonyl oxygen
of C6—represent ideal targets for basic residue
Figure 4. Designs with enhanced cleavage speciﬁcity at a degenerate
target site position. (A) Native mCreI cleaves all four base pair
possibilities at the  8 target site position. (B) This lack of speciﬁcity
reﬂects the presence of a single water-mediated bond from 28K to  8A.
(C) Design 11, in contrast, cleaves only  8G even at high enzyme
concentrations. This and comparable designs with enhanced speciﬁcities
are referred to as Class I designs (see text). (D) The enhanced speciﬁcity
of Design 11 appears to reﬂect the ability of residue substitutions to
specify a G:C base pair at this position: 40T!R donates two hydrogen
bonds to guanine, and 28K!D accepts a hydrogen bond from the
complementary  8C. Neither of these interactions was possible with
the native target site A:T base pair. Native amino acid residues and the
native target site base pair are shown in yellow, design residue substi-
tutions and variant target site base pairs in green, and water molecules
as blue spheres (not to scale). The structure of the native enzyme bound
to native target site DNA is from the co-crystal structure of I-CreI
determined by Chevalier and colleagues (PDB ID 1G9Y). The corres-
ponding structures for designs were computationally generated molecu-
lar models.
Figure 5. Designswithalteredcleavagespeciﬁcityatatargetsiteposition.
(A) Native mCreI preferentially cleaves target sites with  5G, and to a
lesser extent  5A followed by  5C or T. (B) Recognition of the  5
position by native mCreI is mediated by 2 contacts made by residue
68R to  5G, and non-polar contact of 24I with the complementary C.
(C) Design 28 cleaves  5C to near-completion even at 20nM, with minor
activity on  5T. (D) Recognition of  5C in Design 28 is mediated by
24I!K that contacts to the complementary G at  5, and by 68R!T
that prevents potentially deleterious contacts with  5C. Designs with
comparably altered speciﬁcities are referred to as Class II designs.
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chains. The complementary base in a G:C base pair,
cytosine, contains a single electropositive group that can
be bound by any amino acid containing an electronegative
R-group. A:T base pairs, in contrast, contain an electro-
negative atom and either an electropositive group
(adenine) or a methyl group (thymine) that are more dif-
ﬁcult to accommodate by residue substitutions in the
DNA–protein interface. Adenine, for example, can be
contacted by asparagine or glutamine, but only if both
the carbonyl oxygen and the amine groups are correctly
aligned. In turn, contacting a complementary base pair
thymine requires the simultaneous positioning of a polar
group over the carbonyl oxygen and a non-polar group
over the methyl group. Despite these constraints, it should
be possible to improve the rate of design success against
A:T base pairs by improving RD’s energy function and by
better sampling methods. One improvement would be to
allow the protein backbone to move during the design
process. This would increase the allowable atomic pos-
itions for side chains, and substantially increase the like-
lihood of identifying favorably aligned substitutions that
make new, high speciﬁcity contact(s) with design base
pairs.
One appeal of the computational design approach
taken here is that it can be immediately extended as a
general HE engineering approach to other HE proteins
for which there are high resolution co-crystal structures.
Other protein-speciﬁc variables that may facilitate design
success include a DNA–protein interface that is ‘modular’
(i.e. a small number of contacts mediate recognition at
many of the base pair positions); a large number of G:C
base pair design targets; and design target base pair pos-
itions where residue substitutions will have little or no
direct effect on scissile phosphates.
Our results compare favorably with—and substantially
extend—previous efforts to modify I-CreI speciﬁcity: only
7 of our 35 computational design solutions (Designs 5, 7,
9, 10, 15, 22 and 29) had been previously identiﬁed in
prior attempts to engineer I-CreI speciﬁcity (Table 1),
and 11 of our 15 speciﬁcity shifts have not been reported
before. Two interesting prior reports that overlap with our
results include that of Redondo and colleagues who
reported crystallographic structural data that are very
similar to our Design 15 structural predictions (15) (add-
itional data not shown), and 5 individual amino acid sub-
stitutions that appear in our designs with additional
unique substitutions that enhanced cleavage speciﬁcity
(see, e.g. our designs for  4C; Table 1). All of these
previous reports used random mutagenesis and screening
or selection to identify novel speciﬁcity variants of I-CreI
(7,9,10,12,15), or they introduced amino acid mutations
based on predictions from visual inspection of the DNA
interface (17,32).
A major practical challenge at present is how to
combine individual base pair designs to generate HE
proteins with high speciﬁcity and activity against physio-
logic targets that contain multiple base pair differences
from the native target site. There has already been limited
success in combining experimentally identiﬁed I-CreI
residue substitutions to allow the recognition of target
sites with multiple base pair differences [see, e.g. (15,16)].
Figure 6. Designs that selectively broaden mCreI cleavage speciﬁcity. (A and D) Native mCreI cleaves  6C and to a lesser extent  6T at low protein
concentrations, whereas Design 22 permits nearly equal cleavage of the  6G design target base pair as well as  6C or T. (B and C) The 26Q
sidechain in native mCreI contacts the guanine complementary to  6C (B), but cannot make productive contacts with  6G either from 77I or
26Q (C). (E) In Design 22, 77R contacts both the  6G design target base as well as the adjacent  7A. (F) In the presence of the native  6C:G base
pair, 77R pivots to make less favorable contacts to  7A and  8A that permit cleavage but with little base selectivity. Designs with comparably
broadened speciﬁcities are referred to as Class III designs.
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protocol described here should enable the design of HE
proteins with high speciﬁcity and activity against even
these more challenging target sites. The feasibility of a
computational approach has already been demonstrated
by using RD to generate variants of the I-MsoI LHE to
recognize target sites with 1, 3 or 4 contiguous target site
base pair changes (19).
The computational design strategies we employed have
two important practical advantages for the engineering of
HEs or other proteins: they are not protein speciﬁc, and
they are fast. RD provides a comprehensive computation-
al framework for modeling and design that can be applied
immediately to other HE proteins for which there is a
high-resolution structure [examples include I-MsoI
(18,19) as mentioned above and I-AniI (33)]. RD design
protocols are also fast: our comprehensive library of 3200
mCreI designs was generated in automated fashion in
under 12h using modest computational resources. In
contrast, experimental approaches to HE engineering are
time and materials intensive, and require a substantial new
investment for each new HE protein/target site pair.
Moreover, experimental approaches often fail to identify
why problems arise when they do, in contrast to compu-
tational design strategies that make use of prior successes
and failures in a rational and directed manner to facilitate
protein engineering.
Merging computational and experimental approaches
to HE engineering should provide a particularly
powerful, fast and reliable way to generate HE variants
with desired target site speciﬁcities. This can be most
readily achieved at present by using computational
design to generate small pools of high-quality designs
that can then be rapidly subjected to selection or screening
to identify or optimize a desired speciﬁcity. The resulting
HE protein designs should be useful as highly site-speciﬁc
catalysts to enable a wide range of biological, medical and
industrial applications that require precise genome
engineering.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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